XOMA
NASDAQXOMA Royalty Corporation
Price$40.32+5.52 (+15.88%)
2026-04-082026-07-13
News · 26 weeks59+18%
2026-01-182026-07-12
Mix3790d
- Insider22(59%)
- SEC Filings12(32%)
- Earnings1(3%)
- Dividends1(3%)
- Offering1(3%)
Latest news
25 items- INSIDERSEC Form 4 filed by Large owner Bvf Partners L P/Il4 - XOMA Royalty Corp (0000791908) (Issuer)
- INSIDERChief Legal Officer Montano Maricel Perea disposed of 42,371 shares, closing all direct ownership in the company (SEC Form 4) to cover withholding tax4 - XOMA Royalty Corp (0000791908) (Issuer)
- INSIDERDirector Limber Joseph M disposed of 9,532 shares, returned 10,000 units of 8.625% Series A Cumulative Perpetual Preferred Stock to the company and returned 20,000 units of Depositary Shares - 8.375% Series B Cumulative Stock to the company, closing all direct ownership in the company (SEC Form 4) (tax withholding)4 - XOMA Royalty Corp (0000791908) (Issuer)
- INSIDERChief Investment Officer Sitko Bradley disposed of 86,702 shares, returned 395 units of 8.625% Series A Cumulative Perpetual Preferred Stock to the company and returned 9,045 units of Depositary Shares - 8.375% Series B Cumulative Stock to the company, closing all direct ownership in the company (SEC Form 4) to cover withholding tax4 - XOMA Royalty Corp (0000791908) (Issuer)
- INSIDERChief Executive Officer Hughes Owen disposed of 192,016 shares and returned 102,000 units of Depositary Shares - 8.375% Series B Cumulative Stock to the company, closing all direct ownership in the company (SEC Form 4) (tax withholding)4 - XOMA Royalty Corp (0000791908) (Issuer)
- INSIDERDirector Kosacz Barbara disposed of 6,269 shares, closing all direct ownership in the company (SEC Form 4) to cover taxes4 - XOMA Royalty Corp (0000791908) (Issuer)
- INSIDERDirector Wyszomierski Jack L disposed of 21,828 shares, closing all direct ownership in the company (SEC Form 4) to satisfy withholding tax4 - XOMA Royalty Corp (0000791908) (Issuer)
- INSIDERDirector Perry Matthew D disposed of 24,138 shares, closing all direct ownership in the company (SEC Form 4) (withholding obligation)4 - XOMA Royalty Corp (0000791908) (Issuer)
- INSIDERDirector Hernday Natasha disposed of 9,304 shares and returned 4,000 units of 8.625% Series A Cumulative Perpetual Preferred Stock to the company, closing all direct ownership in the company (SEC Form 4) to cover taxes4 - XOMA Royalty Corp (0000791908) (Issuer)
- INSIDERChief Financial Officer Trigilio Jeffrey disposed of 103,906 shares, closing all direct ownership in the company (SEC Form 4) (withholding obligation)4 - XOMA Royalty Corp (0000791908) (Issuer)
- INSIDERDirector Franklin Heather L disposed of 6,269 shares, closing all direct ownership in the company (SEC Form 4) (withholding obligation)4 - XOMA Royalty Corp (0000791908) (Issuer)
- SECXOMA Royalty Corporation filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Entry into a Material Definitive Agreement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update8-K - XOMA Royalty Corp (0000791908) (Filer)
- PRXOMA Royalty Announces Closing of Its Acquisition by LigandEMERYVILLE, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation today announced that Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) has completed its previously announced acquisition of XOMA Royalty. Pursuant to the terms of the transaction announced on April 27, 2026, Ligand acquired all of the outstanding shares of XOMA Royalty common stock. XOMA Royalty stockholders received $39.00 in cash per share of XOMA Royalty common stock owned. XOMA Royalty stockholders and equity award holders also received one non-transferable Contingent Value Right ("CVR") per share entitling the holder to receive a portion of 75% of the net proceeds that may result from certain pending liti
- SECSEC Form DEFA14A filed by XOMA Royalty CorporationDEFA14A - XOMA Royalty Corp (0000791908) (Filer)
- SECXOMA Royalty Corporation filed SEC Form 8-K: Regulation FD Disclosure, Other Events8-K - XOMA Royalty Corp (0000791908) (Filer)
- PRXOMA Royalty Corporation Declares Quarterly Preferred Stock Dividend and Announces Redemption of Its Perpetual Preferred Stock and CVR Dividend Record DateEMERYVILLE, Calif., June 12, 2026 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ:XOMA) ("XOMA" or the "Company") today announced that its Board of Directors has authorized the following cash dividends to holders of XOMA Royalty's (i) 8.625% Series A Cumulative Perpetual Preferred Stock (NASDAQ:XOMAP) (the "Series A Preferred Stock") (984,000 shares outstanding, CUSIP No. 98419J305) and (ii) depositary shares representing its 8.375% Series B Cumulative Perpetual Preferred Stock (NASDAQ:XOMAO) (represented by 1,760,500 Depositary Shares) (the "Series B Preferred Stock", and together with the Series A Preferred Stock, the "Preferred Stock") (CUSIP No. 98419J404). In addition, on July 14
- SECSEC Form DEFM14A filed by XOMA Royalty CorporationDEFM14A - XOMA Royalty Corp (0000791908) (Filer)
- INSIDERDirector Wyszomierski Jack L was granted 3,586 shares, increasing direct ownership by 17% to 25,116 units (SEC Form 4)4 - XOMA Royalty Corp (0000791908) (Issuer)
- INSIDERDirector Limber Joseph M was granted 3,586 shares, increasing direct ownership by 39% to 12,820 units (SEC Form 4)4 - XOMA Royalty Corp (0000791908) (Issuer)
- INSIDERDirector Hernday Natasha was granted 3,586 shares, increasing direct ownership by 40% to 12,592 units (SEC Form 4)4 - XOMA Royalty Corp (0000791908) (Issuer)
- INSIDERDirector Perry Matthew D was granted 3,586 shares, increasing direct ownership by 15% to 27,426 units (SEC Form 4)4 - XOMA Royalty Corp (0000791908) (Issuer)
- INSIDERDirector Franklin Heather L was granted 3,586 shares, increasing direct ownership by 60% to 9,557 units (SEC Form 4)4 - XOMA Royalty Corp (0000791908) (Issuer)
- INSIDERDirector Kosacz Barbara was granted 3,586 shares, increasing direct ownership by 60% to 9,557 units (SEC Form 4)4 - XOMA Royalty Corp (0000791908) (Issuer)
- SECSEC Form 425 filed by XOMA Royalty Corporation425 - XOMA Royalty Corp (0000791908) (Subject)
- SECSEC Form 8-K filed by XOMA Royalty Corporation8-K - XOMA Royalty Corp (0000791908) (Filer)
XOMA FAQ
7 questionsWhat does XOMA Royalty Corporation do?
XOMA Corporation, a biotech royalty aggregator, discovers and develops therapeutic candidates in the United States, Europe, and the Asia Pacific. The company has a pipeline of monoclonal antibodies and technologies to license to pharmaceutical and biotechnology companies to further their clinical development. Its proprietary product candidates include PTH1R program, an anti-parathyroid receptor pipeline to address unmet medical needs, including primary hyperparathyroidism and humoral hypercalcemia of malignancy; XMetA, an insulin receptor-activating antibody to provide long-acting reduction...Where does XOMA stock trade?
XOMA Royalty Corporation (XOMA) is listed on NASDAQ.What sector and industry is XOMA in?
XOMA Royalty Corporation operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did XOMA Royalty Corporation go public?
XOMA Royalty Corporation (XOMA) completed its IPO in 1986.What are analysts saying about XOMA?
XOMA Royalty Corporation has had 7 recent analyst actions on file. The most recent action was from The Benchmark Company: Buy with a $3500.00 price target on 2025-04-17. Recent price targets range from $2200.00 to $4000.00.What companies are similar to XOMA?
Notable peers in the same industry include RZLT (Rezolute Inc.), PALI (Palisade Bio Inc.), YTEN (Yield10 Bioscience Inc.). Compare XOMA side-by-side with any of them on Quantisnow.How can I track XOMA on Quantisnow?
Quantisnow aggregates XOMA Royalty Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow XOMA to receive live email and push alerts on every new disclosure.